Showing results (711-720 of 1,184) with videos related to
Sort By:
Pageof 119
Cancer Cytopathology|April 8, 2020
Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An Italian institutional experience focusing on biosafety proceduresEsther Diana Rossi, Guido Fadda, Antonino Mule, et al.Cancer Cytopathology|May 29, 2020
Comparative analysis of programmed death ligand 1 expression in paired cytologic and histologic specimens of non-small cell lung cancerMatteo Daverio, Filippo Patrucco, Francesco Gavelli, et al.Cancer Cytopathology|June 14, 2017
Specimen acquisition: ROSEs, gardeners, and gatekeepersAdele O KraftCancer Cytopathology|June 14, 2017
The role of informatics in patient-centered care and personalized medicineMatthew G Hanna, Liron PantanowitzCancer Cytopathology|June 14, 2017
Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?Ayse M Onenerk, Marc P Pusztaszeri, Sule Canberk, et al.Cancer Cytopathology|June 6, 2017
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literatureEsther Diana Rossi, Maurizio Martini, Tonia Cenci, et al.Cancer Cytopathology|September 21, 2016
Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cystsMatthew W Rosenbaum, Martin Jones, Jonathan C Dudley, et al.Cancer Cytopathology|June 3, 2017
Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancerYimin Ge, Paul Christensen, Eric Luna, et al.Cancer Cytopathology|March 9, 2010
Malignant solitary fibrous tumor: cytopathologic findings and differential diagnosisJustin A Bishop, Natasha Rekhtman, Joyce Chun, et al.Cancer Cytopathology|May 26, 2018
Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytologyHuina Zhang, Kavita R Varma, Min Han, et al.Pageof 119